Onconic Therapeutics Inc. (KOSDAQ:476060)
13,450
-550 (-3.93%)
Jun 30, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 635.71 billion as of June 30, 2026. Its market cap has increased by 163.83% in one year.
Market Cap
635.71B
Enterprise Value
578.52B
Revenue
67.20B
Ranking
n/a
PE Ratio
31.74
Stock Price
13,450.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 635.71B, an increase of 240.12%. That is a compound annual growth rate of 123.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 635.71B | -26.91% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.07T |
| Chabiotech | 969.43B |
| Pharmicell | 710.29B |
| GI Innovation | 623.34B |
| Medy-Tox | 485.08B |
| GC Corp. | 441.76B |
| MEDIPOST | 315.03B |
| SillaJen | 303.43B |